Literature DB >> 24627031

Tumor necrosis factor-α synergistically enhances polyinosinic-polycytidylic acid-induced toll-like receptor 3 signaling in cultured normal human mesangial cells: possible involvement in the pathogenesis of lupus nephritis.

Tadaatsu Imaizumi1, Tomomi Aizawa, Ryo Hayakari, Fei Xing, Pengfei Meng, Kazushi Tsuruga, Tomoh Matsumiya, Hidemi Yoshida, Liang Wang, Tetsuya Tatsuta, Hiroshi Tanaka.   

Abstract

AIM: It has been reported that tumor necrosis factor (TNF)-α plays dual controversial roles, beneficial or detrimental, in the pathogenesis of murine lupus nephritis (LN). However, its precise role in the development of human LN remains to be determined.
METHODS: We examine the effect of pretreatment with TNF-α on the toll-like receptor 3 (TLR3) signaling induced by polyinosinic-polycytidylic acid (poly IC), a synthetic analog of viral dsRNA that makes "pseudoviral" infection in cultured normal human mesangial cells, and analyzed the expression of CC chemokine ligand 5 (CCL5) via TLR3/interferon (IFN)-β/retinoic acid-inducible gene-I (RIG-I) pathway by reverse transcriptase-polymerase chain reaction, Western blotting and enzyme-linked immunosorbent assay.
RESULTS: We found synergistic effect of TNF-α, even at low level, on the expression of CCL5 induced by poly IC in a concentration-dependent manner, in comparison with that by poly IC alone. Knockdown of either IFN-β or RIG-I decreased CCL5 expression induced by TNF-α followed by poly IC.
CONCLUSION: Pretreatment with TNF-α leads marked activation of the TLR3/IFN-β/RIG-I/CCL5 axis induced by "pseudoviral" infection. Since chronic local activation of proinflammatory cytokines including TNF-α in resident renal cells may exist in patients with active lupus, synergistic effect of TNF-α and "pseudoviral" infection is possibly involved in the development of LN.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24627031     DOI: 10.1007/s10157-014-0956-3

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  21 in total

1.  Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity.

Authors:  Mitsutoshi Yoneyama; Mika Kikuchi; Kanae Matsumoto; Tadaatsu Imaizumi; Makoto Miyagishi; Kazunari Taira; Eileen Foy; Yueh-Ming Loo; Michael Gale; Shizuo Akira; Shin Yonehara; Atsushi Kato; Takashi Fujita
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

2.  Messenger RNA expression of RANTES in the urinary sediment of patients with lupus nephritis.

Authors:  Rebecca Wing-Yan Chan; Fernand Mac-Moune Lai; Edmund Kwok-Ming Li; Lai-Shan Tam; Kai-Ming Chow; Philip Kam-Tao Li; Cheuk-Chun Szeto
Journal:  Nephrology (Carlton)       Date:  2006-06       Impact factor: 2.506

3.  Expression of retinoic acid-inducible gene-I in lupus nephritis.

Authors:  Koichi Suzuki; Tadaatsu Imaizumi; Koji Tsugawa; Etsuro Ito; Hiroshi Tanaka
Journal:  Nephrol Dial Transplant       Date:  2007-04-01       Impact factor: 5.992

4.  Glomerular expression of fractalkine is induced by polyinosinic-polycytidylic acid in human mesangial cells: possible involvement of fractalkine after viral infection.

Authors:  Tomomi Aizawa-Yashiro; Tadaatsu Imaizumi; Kazushi Tsuruga; Shojiro Watanabe; Tomoh Matsumiya; Ryo Hayakari; Hidemi Yoshida; Kei Satoh; Etsuro Ito; Hiroshi Tanaka
Journal:  Pediatr Res       Date:  2012-11-20       Impact factor: 3.756

5.  Glomerular expression of myxovirus resistance protein 1 in human mesangial cells: possible activation of innate immunity in the pathogenesis of lupus nephritis.

Authors:  Shojiro Watanabe; Tadaatsu Imaizumi; Kazushi Tsuruga; Tomomi Aizawa; Tatsuya Ito; Tomoh Matsumiya; Hidemi Yoshida; Kensuke Joh; Etsuro Ito; Hiroshi Tanaka
Journal:  Nephrology (Carlton)       Date:  2013-12       Impact factor: 2.506

Review 6.  Interferon-alpha and -beta in kidney inflammation.

Authors:  Hans-Joachim Anders; Julia Lichtnekert; Ramanjaneyulu Allam
Journal:  Kidney Int       Date:  2010-03-17       Impact factor: 10.612

Review 7.  Toll-like receptors and renal disease.

Authors:  Michael G Robson
Journal:  Nephron Exp Nephrol       Date:  2009-07-09

Review 8.  The role of cytokines in the pathogenesis of systemic lupus erythematosus - from bench to bedside.

Authors:  Desmond Yat Hin Yap; Kar Neng Lai
Journal:  Nephrology (Carlton)       Date:  2013-04       Impact factor: 2.506

9.  TNF alpha induces expression of the chemoattractant cytokine RANTES in cultured mouse mesangial cells.

Authors:  G Wolf; S Aberle; F Thaiss; P J Nelson; A M Krensky; E G Neilson; R A Stahl
Journal:  Kidney Int       Date:  1993-10       Impact factor: 10.612

10.  Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.

Authors:  Martin Aringer; Frederic Houssiau; Caroline Gordon; Winfried B Graninger; Reinhard E Voll; Eva Rath; Guenter Steiner; Josef S Smolen
Journal:  Rheumatology (Oxford)       Date:  2009-09-11       Impact factor: 7.580

View more
  5 in total

Review 1.  Mesangial Cells in Lupus Nephritis.

Authors:  Tamara K Nowling
Journal:  Curr Rheumatol Rep       Date:  2022-01-05       Impact factor: 4.592

2.  Clarithromycin attenuates the expression of monocyte chemoattractant protein-1 by activating toll-like receptor 4 in human mesangial cells.

Authors:  Koji Tsugawa; Tadaatsu Imaizumi; Shojiro Watanabe; Kazushi Tsuruga; Hidemi Yoshida; Hiroshi Tanaka
Journal:  Clin Exp Nephrol       Date:  2016-09-10       Impact factor: 2.801

3.  Let-7 miRNAs Modulate the Activation of NF-κB by Targeting TNFAIP3 and Are Involved in the Pathogenesis of Lupus Nephritis.

Authors:  Jun Liu; Lin Zhu; Guang-liang Xie; Jing-fang Bao; Qing Yu
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

Review 4.  Toll-like receptors in lupus nephritis.

Authors:  Satish Kumar Devarapu; Hans-Joachim Anders
Journal:  J Biomed Sci       Date:  2018-04-12       Impact factor: 8.410

5.  Elevated levels of CCR6+ T helper 22 cells correlate with skin and renal impairment in systemic lupus erythematosus.

Authors:  Wei Zhong; Yanfang Jiang; Hongshuang Ma; Jiang Wu; Zhenyu Jiang; Ling Zhao
Journal:  Sci Rep       Date:  2017-10-11       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.